Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Carcinoma Breast Stage IV
Interventions: DRUG: Bavituximab
Sponsor: Peregrine Pharmaceuticals